Novel Use Of Hydroxyurea in an African Region With Malaria
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- Acronyms NOHARM
- 26 Nov 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 22 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Oct 2017.